Revolutionising cellular therapies for cancer and beyond
We’re developing more precise and more accessible treatment options for patients with solid cancers, endometriosis and Alzheimer’s disease
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.
Some of our partners
Latest news
Cartherics Corporate Adviser Dr Ian Nisbet talks about ‘what pisses him off’
By Christine Filippis / November 22, 2018
WHAT PISSES ME OFF When it comes to taking ideas to market, Corporate Advisor Ian Nisbet says America’s entrepreneurial ethos...
Read More
Communications Adviser Leigh Dayton talks to Cartherics Scientific Board member Jacques Miller – the man who discovered the function of the thymus gland yet didn’t win the Nobel Prize.
By Christine Filippis / November 9, 2018
IMMUNOLOGIST Jacques Miller did not win this year’s Nobel Prize in Physiology or Medicine. He didn’t win it last year...
Read More
Communications Adviser Leigh Dayton talked with cancer immunologist Ashleigh Unsworth
By carth_admin / October 15, 2018
WELCOME to The Pipeline, the place where Cartherics team members share occasional news and views. To get things rolling, Communications...
Read More
